Work

Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML ‐ M4 and AML ‐ M5 , Treated With Venetoclax Plus Azacitidine

Year: 2026

Type: article

Abstract: and AML-M5, Treated With Myeloid Leukemia, Including AML-M4 and AML-M5, Treated With Venetoclax Plus Azacitidine Venetoclax Plus Azacitidine

Source: American Journal of Hematology

DOI: 10.1002/ajh.70161

Authors: Marina Konopleva, Courtney D. DiNardo, Yan Sun, Paul Jung, Sanam Loghavi, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea

Institutions: Montefiore Einstein Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, AbbVie (United States), Genentech, University of Colorado Anschutz

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,450

Funders: AbbVie, Genentech

OpenAlex ID: W7118230749

FWCI: 18.07

Cites: 13

Cited by: 4

Related to: